Polymorphisms in CYP2A13 and UGT1A7 genes and head and neck cancer susceptibility in North Indians

Oral Diseases

Volumn 16, Issue 8, 2010, Pages 760-768

  Sharma, R ^a   Ahuja, M ^a   Panda, N K ^a   Khullar, M ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

CYP2A13; Genetic polymorphisms; Haplotypes; Head and neck cancer; Smoking; UGT1A7

Indexed keywords

CARCINOGEN; CYTOCHROME P450; CYTOCHROME P450 2A13; GLUCURONOSYLTRANSFERASE 1A7; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEAD AND NECK CANCER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARYNX CANCER; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TOBACCO;

ALCOHOL DRINKING; ARYL HYDROCARBON HYDROXYLASES; CARCINOGENS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CODON; COHORT STUDIES; CYTOSINE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; GLUCURONOSYLTRANSFERASE; HAPLOTYPES; HEAD AND NECK NEOPLASMS; HETEROZYGOTE; HUMANS; INDIA; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; SMOKING; THYMINE; TOBACCO;

EID: 77958195033     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2010.01683.x     Document Type: Article

References (30)

1. Bird TD, Jarvik GP, Wood NW (2001). Genetic association studies. Neurology 57: 1153-1154.
2. Buch SC, Notani PN, Bhisey RA (2002). Polymorphisms at GSTM1, GSTM3 and GSTT1 gene loci and susceptibility to oral cancer in an Indian population. Carcinogenesis 23: 803-807.
3. Cauffiez C, Lo-Guidice JM, Quaranta S et al (2004). Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibility. Biochem Biophys Res Commun 317: 662-669.
4. Cauffiez C, Pottier N, Tournel G et al (2005). CYP2A13 genetic polymorphism in French Caucasian, Gabonese and Tunisian populations. Xenobiotica 35: 661-669.
5. Choi SY, Kahyo H (1991). Effect of cigarette smoking and alcohol consumption in the aetiology of cancer of the oral cavity, pharynx and larynx. Int J Epidemiol 20: 878-885.
6. Day DA, Tuite MF (1998). Post-transcriptional gene regulatory mechanisms in eukaryotes: an overview. J Endocrinol 157: 361-371.
7. Feng FY, Liang G, Lu WF et al (2005). Correlation of polymorphisms of UDP-glucuronosyltransferase 1A7 gene to genetic susceptibility of lung cancer. Ai Zheng 24: 1085-1090.
8. Guillemette C, Ritter JK, Auyeung DJ et al (2000). Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene. Pharmacogenetics 10: 629-644.
9. Hahn LW, Ritchie MD, Moore JH (2003). Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19: 376-382.
10. Hegele RA, Ramdath DD, Ban MR et al (2001). Polymorphisms in PNLIP, encoding pancreatic lipase and associations with metabolic traits. J Hum Genet 46: 320-324.
11. Jiang JH, Jia WH, Chen HK et al (2004). Genetic polymorphisms of CYP2A13 and relationship to nasopharyngeal carcinoma in Cantonese population. J Transl Med 2: 24-31.
12. Lacko M, Roelofs HM, Te Morsche RH et al (2009). Genetic polymorphisms in the tobacco smoke carcinogens detoxifying enzyme UGT1A7 and the risk of head and neck cancer. Head Neck 31: 1274-1281.
13. Lankisch TO, Vogel A, Eilermann S et al (2005). Identification and characterization of a functional TATA box polymorphism of the UDP glucuronosyltransferase 1A7 gene. Mol Pharmacol 67: 1732-1739.
14. Ling G, Wei Y, Ding X (2007). Transcriptional regulation of human CYP2A13 expression in the respiratory tract by CCAAT/enhancer binding protein and epigenetic modulation. Mol Pharmacol 71: 807-816.
15. Van Der Logt EM, Bergevoet SM, Roelofs HM et al (2004). Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk. Carcinogenesis 25: 2407-2415.
16. Nagar S, Remmel RP (2006). Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer. Oncogene 25: 1659-1672.
17. Notani PN (2001). Global variation in cancer incidence and mortality. Curr Sci 81: 465-474.
18. Parkin DM, Bray F, Ferlay J et al (2005). Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
19. Piepoli A, Gentile A, Valvano MR et al (2006). Lack of association between UGT1A7, UGT1A9, ARP, SPINK1 and CFTR gene polymorphisms and pancreatic cancer in Italian patients. World J Gastroenterol 12: 6343-6348.
20. Song DK, Xing DL, Zhang LR et al (2009). Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China. Cancer Detect Prev 32: 416-423.
21. Stenirri S, Fermo I, Battistella S et al (2004). Denaturing HPLC profiling of the ABCA4 gene for reliable detection of allelic variations. Clin Chem 50: 1336-1343.
22. Strassburg CP, Nguyen N, Manns MP et al (1998). Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium. Mol Pharmacol 54: 647-654.
23. Strassburg CP, Vogel A, Kneip S et al (2002). Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer. Gut 50: 851-856.
24. Su T, Bao Z, Zhang Q-Y et al (2000). Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco specific carcinogen, 4-methylnitroso-1-(3-pyridyl)-1-butanone. Cancer Res 60: 5074-5079.
25. Tephly TR, Burchell B (1990). UDP-glucuronosyltransferases: a family of detoxifying enzymes. Trends Pharmacol Sci 11: 276-279.
26. Wang H, Tan W, Hao B et al (2003). Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK. Cancer Res 63: 8057-8061.
27. Zhang X, Su T, Zhang QY et al (2002). Genetic polymorphisms of the human CYP2A13 gene: identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant. J Pharmacol Exp Ther 302: 416-423.
28. Zhang X, Chen Y, Liu Y et al (2003). Single nucleotide polymorphisms of the human CYP2A13 gene: evidence for a null allele. Drug Metab Dispos 31: 1081-1085.
29. Zhang X, Caggana M, Cutler TL et al (2004). Development of a real-time polymerase chain reaction-based method for the measurement of relative allelic expression and identification of CYP2A13 alleles with decreased expression in human lung. J Pharmacol Exp Ther 311: 373-381.
30. Zheng Z, Park JY, Guillemette C et al (2001). Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk. J Natl Cancer Inst 93: 1411-1418.